Sigilon Revenue and Competitors
Estimated Revenue & Valuation
- Sigilon's estimated annual revenue is currently $11.4M per year.
- Sigilon's estimated revenue per employee is $153,649
- Sigilon's total funding is $263.2M.
- Sigilon's current valuation is $68.5M. (January 2022)
Employee Data
- Sigilon has 74 Employees.
- Sigilon grew their employee count by -24% last year.
Sigilon Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $7M | 45 | 73% | N/A | N/A |
#10 | $5.4M | 35 | 3% | N/A | N/A |
What Is Sigilon?
Harnessing the full power of cell therapeutics. Cambridge, MA
keywords:N/A
$263.2M
Total Funding
74
Number of Employees
$11.4M
Revenue (est)
-24%
Employee Growth %
$68.5M
Valuation
N/A
Accelerator
Sigilon's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Associate Director, CMC Analytical Development | Reveal Email/Phone |
3 | VP, IMD | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | VP, Intellectual Property Counsel | Reveal Email/Phone |
6 | Chief Legal and Admin Officer | Reveal Email/Phone |
7 | Principal Scientist | Reveal Email/Phone |
8 | Head Supply Chain | Reveal Email/Phone |
9 | Director, Preclinical & CMC Project Management Operations | Reveal Email/Phone |
10 | Senior Manager, Process Development | Reveal Email/Phone |
Sigilon News
2022-04-17 - Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus ...
Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Given Consensus Rating of Buy by Brokerages. Posted by admin on Apr 22nd, 2022.
2022-03-30 - How Will the Market React to Sigilon Therapeutics Inc (SGTX) Stock Getting
a Bullish Rating
The market has been high on Sigilon Therapeutics Inc (SGTX) stock recently. SGTX gets a Bullish score from InvestorsObserver Stock Sentiment...
2022-03-22 - Sigilon Therapeutics Reports Fourth Quarter and Full Year ...
Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of chronic diseases by harnessing the power of the human...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 74 | -14% | N/A |
#2 | $13.7M | 74 | 12% | N/A |
#3 | $7.5M | 74 | 0% | N/A |
#4 | $7.5M | 75 | -5% | N/A |
#5 | $9.5M | 75 | 7% | N/A |